Bromocriptine Mesylate and Ocrelizumab Intravenous
Determining the interaction of Bromocriptine Mesylate and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Ocrevus
- Bromocriptine Mesylate-Octagam
- Bromocriptine Mesylate-Octagam Gammagard S/D
- Bromocriptine Mesylate-Octocaine
- Bromocriptine Mesylate-Octocaine 100
- Bromocriptine Mesylate-OctreoScan
- Ocrelizumab Intravenous-Brompheniramine
- Ocrelizumab Intravenous-Brompheniramine and codeine
- Ocrelizumab Intravenous-Brompheniramine and phenylephrine
- Ocrelizumab Intravenous-Brompheniramine and Phenylephrine Chewable Tablets
- Ocrelizumab Intravenous-Brompheniramine and Phenylephrine Liquid
- Ocrelizumab Intravenous-Brompheniramine and Phenylephrine Suspension